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Edited by Gianni CesareniAbstract We identiﬁed intersectin1 (ITSN1) as a new binding
partner of the SH2 domain containing inositol 5-phosphatase 2
(SHIP2). The interaction between SHIP2 and ITSN1 was con-
ﬁrmed in vivo. Src homology 3D, A, C, and E domains of ITSN1
were shown to be implicated in the interaction. In response to
epidermal growth factor, SHIP2 expression could recruit the
ITSN1 short form (ITSN1-S) to the cell membrane, while
SHIP2 overexpression did not modulate the ITSN-mediated
extracellular signal-regulated kinase1/2 and c-Jun NH2-termi-
nal kinase activation. Our data provide a molecular link between
SHIP2 and ITSN1 which are involved in receptor endocytosis
regulation.
Structured summary:
MINT-6673604:
ITSN-1S (uniprotkb:Q15811-2) and SHIP2 (uniprotkb:
O15357) colocalize (MI:0403) by ﬂuorescence microscopy
(MI:0416)
MINT-6673646, MINT-6694843:
SHIP2 (uniprotkb:Q6P549) physically interacts (MI:0218) with
ITSN-1S (uniprotkb:Q9Z0R4-2) by anti bait coimmunoprecip-
itation (MI:0006)
MINT-6673386:
SHIP2 (uniprotkb:O15357) physically interacts (MI:0218) with
ITSN-1S (uniprotkb:Q15811-2) by two hybrid (MI:0018)
MINT-6673429, MINT-6673447, MINT-6673475:
ITSN-1S (uniprotkb:Q15811-2) physically interacts (MI:0218)
with SHIP2 (uniprotkb:O15357) by anti tag coimmunoprecipi-
tation (MI:0007)
MINT-6673513, MINT-6673542, MINT-6673557, MINT-6673572:
ITSN-1S (uniprotkb:Q15811-2) physically interacts (MI:0218)
with SHIP2 (uniprotkb:O15357) by pull down (MI:0096)
MINT-6673462:
ITSN-1L (uniprotkb:Q15811-1) physically interacts (MI:0218)
with SHIP2 (uniprotkb:O15357) by anti tag coimmunoprecipi-
tation (MI:0007)
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Scaﬀold protein1. Introduction
The src homology 2 (SH2)-domain containing inositol 5-
phosphatase 2 (SHIP2) is a member of the inositol 5-phospha-
tases family that dephosphorylate the 5-position of the inositol
ring of phosphoinositides [1]. SHIP2 mainly dephosphorylates
phosphatidylinositol (3,4,5)-triphosphate (PtdIns(3,4,5)P3)
into PtdIns(3,4)-bisphosphate (PtdIns(3,4)P2) and thereby
inhibits cellular responses elicited by the phosphoinositide 3-
kinase activation [1]. SHIP2 contains a variety of protein inter-
action domains: SH2 domain in its N-terminal part, a catalytic
domain in the central part, proline-rich (PR) regions in both
N- and C-terminal parts, a NPXY site and a sterile a motif
(SAM) domain in the C-terminal region [2]. SHIP2 is tyrosine
phosphorylated following stimulations such as various growth
factors and insulin. Nevertheless, the physiological signiﬁcance
of this phosphorylation is still unknown [3].
Studies in knockout mice have provided evidence that
SHIP2 plays a role in enhancing insulin sensitivity and regu-
lating obesity in vivo [4,5]. Cellular roles proposed for SHIP2
so far concern remodelling of actin structures, cell adhesion
and spreading and receptor endocytosis. SHIP2 has been
shown to be implicated in actin remodelling in COS-7 cells
through its interaction with ﬁlamin [6] and in cell adhesion
and spreading in HeLa and COS-7 cells through its interac-
tion with p130Cas [7] and Vinexin [8], respectively. Further-
more, RNAi knockdown of SHIP2 causes marked actin
abnormalities and cell-spreading defects [9]. SHIP2 is also in-
volved in receptor endocytosis and degradation. Indeed,
SHIP2 previously reported as participating in epidermal
growth factor (EGF) receptor pathway [3], was recently de-
scribed as regulating epidermal growth factor receptor
(EGFR) internalization and degradation [9]. By decreasing
the level of PtdIns(3,4,5)P3, SHIP2 inhibited EphA2 receptor
endocytosis via a phosphatidylinositol 3-Kinase-dependent
Rac1 activation [10]. In COS-7 cells treated with EGF [3]
or in rat vascular smooth muscle cells treated with PDGF
or IGF-1 [11], transfected SHIP2 decreases the levels of
PtdIns(3,4,5)P3. Akt/PKB and mitogen activated protein
(MAP) kinase activities were also decreased, suggesting that
SHIP2 is a down-regulator of both arms of receptor tyrosine
kinases activation [3].blished by Elsevier B.V. All rights reserved.
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identiﬁed intersectin1 (ITSN1) as a new partner of SHIP2.
ITSN1 is a multi-domain protein which plays a role in endocy-
tosis, mitogen activated protein kinase (MAPK) signalling and
actin cytoskeleton [12–14]. The interaction between SHIP2 and
ITSN1 was conﬁrmed in overexpression systems as well as at
the physiological concentration with the endogenously ex-
pressed proteins. Diﬀerent Src homology 3 (SH3) domains of
ITSN1 are potentially involved in this interaction. Under the
stimulation of EGF, the expression of SHIP2 may recruit
ITSN1 short form (ITSN1-S) to cell membrane. The ITSN-
mediated extracellular signal-regulated kinase (ERK)1/2 and
c-Jun NH2-terminal kinase (JNK) activations were not modu-
lated when SHIP2 was overexpressed. The link between SHIP2
and ITSN may provide one of the molecular mechanisms used
by SHIP2 to participate in receptor endocytosis regulation.2. Materials and methods
2.1. Plasmids and antibodies
pGBT9-SHIP2-PR, His-Xpress tagged SHIP2 and TSHIP2 vectors
and the rabbit polyclonal C-terminal SHIP2 antibody have been de-
scribed previously [15], Anti-SHIP2X5A antibody was produced via
Eurogentec (Eurogentec S.A., LIEGE Science Park, Belgium) with
the same immunogenic peptide as SHIP2 antibody described previ-
ously. Hemagglutinin (HA)-SHIP2 was kindly provided by Christina
Mitchell (Monash University, Melbourne, Australia). Human trun-
cated intersectin (ITSN-tr) was subcloned from two-hybrid puriﬁed
pACT2 into pcDNA3. Myc-ITSN1 long form (ITSN1-L) was kindly
provided by Dr. Sean E. Egan (The Hospital for Sick Children,
Toronto,Canada).HA-ITSN1-S, 1-L, 2-S and 2-Lwere kindly provided
by Prof. Susana de la Luna (Center forGenomicRegulation, Barcelona,
Spain). pEBG-ITSN-SH3A, B, C, D, and E mutants were produced by
PCR using the pcDNA3-HA-ITSNl as template. Sense primers were 5 0
GCACTAGTCTTACCATTTCTGCACAGG 3 0, 5 0 GCACTAGTC-
CGTCTCCGTTGCTAGGC 3 0, 5 0 GCACTAGTCGAGTAGCC-
TCTCCAGC 3 0, 5 0 GCACTAGTGGCTCTGGAACTGCTGGG
3 0and 5 0 GCACTAGTACAGAGCCACCTAAGTC 3 0, respectively,
and antisense primers were 5 0 CTCTAGAGCGGCCGCTGTTT-
CACTGGAGCGG 3 0, 5 0 CTCTAGAGCGGCCGCTTGTAGACT-
TCCTTATGGG 3 0, 5 0 CTCTAGAGCGGCCGCCCCAGCAGTTC-
CAGAGCC 3 0, 5 0 CTCTAGAGCGGCCGCTTAGGTGGCTCTG-
TTGG 3 0 and 5 0 CTCTAGAGCGGCCGCATTGCTGGCTTGGG-
TC 3 0, respectively. The mouse monoclonal anti-HA antibody, Fugene
6 and Complete protease inhibitors cocktail were from Roche
(Vilvoorde, Belgium). The mouse monoclonal anti-HIS6 and anti-ITSN
antibodies were from BD Biosciences (Erembodegem, Belgium), G-Se-
pharose was from Amersham Pharmacia Biotech (AT Roosendaal,
The Netherlands) and ECL kit was from Perkin–Elmer (Fremont,
CA, USA). Glutathione agarose beads, anti-Xpress and anti-myc anti-
bodies were purchased from Sigma (Saint Louis, Missouri, USA). Pre-
immune rabbit serum was from Jackson ImmunoResearch (West
Grove, PA, USA). Anti-phospho-ERK1/2 and anti-ERK1/2 antibod-
ies were from Cell Signaling (Leiden, The Netherlands), anti-phos-
pho-JNK and anti-JNK1 antibodies were from Santa Cruz
Biotechnology (Santa Cruz, USA).
2.2. Yeast two-hybrid screening
Two-hybrid screening was described previously [15].
2.3. Cell culture and transfections
COS-7 cells were cultured in Dulbeccos modiﬁed Eagles medium
supplemented with 10% FBS, 2% penicillin/streptomycin, 1% sodium
pyruvate and 1% fungizone (Gibco, Paisley, UK). COS-7 cells (plated
at 1.2 · 106 cells/dish the previous day) were transfected in 10-cm
dishes using the Fugene 6 according to the manufacturers instructions.
Cells were starved for 12 h before stimulation with 50 ng/ml EGF for
5 min or 15 min at 37 C. C2C12 and 3T3 cells culture were described
previously [16].2.4. Immunoprecipitation, Western blot analysis and
immunoﬂuorescence
Immunoprecipitation and Western blot were carried out as previ-
ously described [16]. For immunoﬂuorescence analysis, COS-7 cells
transiently transfected with the vectors encoding HA-ITSN1-S and
His-SHIP2 using Fugene 6 were seeded on 15 mm coverslips in
30 mm dishes. Thirty-six hours after transfection, cells were starved
for 4 h and stimulated with or without 50 ng/ml EGF for 1, 5, 15,
30, 60 min, respectively. The cells were rinsed with phosphate-buﬀered
saline (PBS) and ﬁxed with 4% fresh paraformaldehyde in PBS on ice
for 15 min. After permeabilization with 0.2% Triton X-100 and treat-
ment with 0.1% of NaBH4 (sodium tetrahydroborate), ITSN1-S and
SHIP2 were visualized using anti-HA (1:100) and anti-SHIP2 (1:250)
antibodies, respectively, followed by anti-mouse-FITC (1/200) and
anti-rabbit-Texas Red (1/50) secondary antibodies, respectively.3. Results
3.1. Identiﬁcation of intersectin as a novel SHIP2 binding
partner
In a previous search for new protein partners of SHIP2, the
C-terminal PR domain of SHIP2 (Fig. 1A) was used as a two-
hybrid bait to screen 6 · 105 transformants of a human brain
cDNA library (BD Clontech). Sequence analysis of the posi-
tive clones identiﬁed one cDNA (truncated intersectin1, amino
acid 331–1220), referred as ITSN-1S-tr encoding the C-termi-
nal part of the previously identiﬁed human ITSN1-S protein
[17] (Fig. 1A). In two-hybrid interaction tests, ITSN1-S-tr spe-
ciﬁcally interacted with SHIP2-PR in yeast, but not with the
GAL4-DBD alone (Fig. 1B). Interestingly, no interaction of
ITSN1S-tr was observed with either the PR domain of SHIP1
or Type I Ins(1,4,5)P3 5-phosphatase (Fig. 1B).
To examine whether full-length SHIP2 and ITSN interact in
mammalian cells, HA-ITSN1-S-tr was transiently expressed
with full-length His-SHIP2. The interaction was conﬁrmed
by anti-HA co-immunoprecipitation (Fig. 1C). The full-length
HA-tagged ITSN1-S and myc-tagged ITSN1-L showed no
interaction with SHIP1 (data not shown), but interact with
SHIP2 (Fig. 1D and E), which is consistent to two-hybrid
study (Fig. 1B). The similar results were obtained for
ITSN2-S and 2-L which were also observed to associate with
SHIP2 (data not shown).
3.2. Intersectin and SHIP2 associate endogenously
To examine whether this interaction takes place in non-over-
expressing systems, we investigated the endogenous associa-
tion of ITSN and SHIP2 in COS-7, undiﬀerentiated or
diﬀerentiated C2C12, diﬀerentiated 3T3 cells and mice brain
extracts (Fig. 2). Endogenous SHIP2 was immunoprecipitated
followed by immunoblot with anti-ITSN antibody. Pre-im-
mune rabbit serum was used for immunoprecipitation as neg-
ative control. SHIP2 and ITSN did not co-immunoprecipitate
in diﬀerentiated 3T3 cells extracts and mice brain extracts, but
faintly associated in COS-7 cells. Interestingly, in diﬀerentiated
or undiﬀerentiated C2C12 cells, SHIP2 associated with ITSN
evidently. Although ITSN long form was expressed in diﬀeren-
tiated 3T3 cells, no interaction could be observed between
SHIP2 and ITSN long form in these experimental conditions.
3.3. C-terminal PR domain of SHIP2 mediates binding with
ITSN-SH3D, A, C and E domains
PR domain is a well known protein–protein interacting do-
main supposed to bind SH3 domain. Truncated-ITSN1 frag-
Fig. 1. SHIP2 is a new protein partner for ITSN. (A) Schematic representation of SHIP2, Intersectin short (-S) and long (-L) forms, the bait (SHIP2-
PR) and the target identiﬁed (ITSN1-S-tr) in the yeast two-hybrid screening. (B) Yeasts expressing Gal4-DBD, Gal4-DBD-SHIP2-PR or Gal4-DBD-
Type I Ins(1,4,5) 5-phosphatase baits (upper panel) or yeast expressing Gal4-DBD-SHIP2-PR or Gal4-DBD-SHIP1-PR baits (lower panel) were
transformed with Gal4-AD-ITSN1-tr and plated on medium lacking tryptophan, leucine, adenine, and histidine. (C) COS-7 cells were transfected
with His-SHIP2 and HA-ITSN1-S-tr. Anti-HA immunoprecipitates were immunoblotted with anti-SHIP2 and anti-HA antibodies. (D) COS-7 cells
were transfected with His-Xpress-SHIP2 and HA-ITSN1-S. Anti-Xpress immunoprecipitates were immunoblotted with anti-SHIP2 and anti-HA
antibodies. (E) COS-7 cells were transfected with HA–SHIP2 and myc-ITSN1-L. Anti-myc immunoprecipitates were immunoblotted with both anti-
HA and anti-myc mixed antibodies at the same time. Experiments were repeated three times with similar results.
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SHIP2 as a bait, indeed contain the SH3 domains of ITSN.
In COS-7 cells, HA-ITSN1-S co-immunoprecipitated with
SHIP2, but not with TSHIP2 which does not contain C-termi-
nal PR domain (schematized in Fig. 3A) (Fig. 3B), conﬁrming
that the C-terminal PR region of SHIP2 is necessary to medi-
ate the association with ITSN1. We also observed that
TSHIP2 did not interact with ITSN1-L, 2-S or 2-L (data not
shown).
Further, we sought to determine which SH3 domain was
responsible for the SHIP2-ITSN association. Five SH3 do-
mains (A, B, C, D, E) of ITSN1 were, respectively, co-expressed
with SHIP2 in COS-7 cells. Glutathione S-transferase (GST)-
tagged SH3 domains were pulled down using glutathione beads
and the protein complex were analysed by SDS–PAGE (Fig.3C). The immunoblot with anti-SHIP2 antibody showed that
ITSN1-SH3D, A, C and E domains interacted with SHIP2.
While SH3B domain did not interact. Considering the quantity
of total GST-ITSN1-SH3 domains pulled down by beads, we
concluded the binding aﬃnity of SH3 domains as SH3D >
SH3A > SH3C > SH3E.
3.4. SHIP2 recruits ITSN1-S to cell membrane upon EGF
stimulation
Since both SHIP2 and ITSN were shown to be implicated in
EGF receptor internalisation process, respectively [9,18], we
investigated the cellular localization of both proteins under ba-
sal state and EGF stimulation. COS-7 cells were transiently
transfected with SHIP2 alone, ITSN1-S alone or both proteins
together. Anti-SHIP2X5A and anti-HA antibodies were used
Fig. 2. Endogenous interaction between SHIP2 and intersectin.
Endogenous SHIP2 was immunoprecipitated from extracts of COS-
7, undiﬀerentiated and diﬀerentiated C2C12, diﬀerentiated 3T3 cells
and mice brain. The immunoprecipitates were immunoblotted with
anti-ITSN and anti-SHIP2X5A antibodies. Experiments were repeated
three times with similar results.
Fig. 3. C-terminal PR domain of SHIP2 mediates binding with ITSN
SH3 domains A, D and C. (A) Schematic representation of SHIP2 and
TSHIP2. (B) COS-7 cells were transfected with His-Xpress-SHIP2 or
His-Xpress-TSHIP2 and HA-ITSN1-S. Anti-Xpress immunoprecipi-
tates were immunoblotted with anti-SHIP2X5A, anti-His and anti-HA
antibodies. (C) COS-7 cells were transfected with His-Xpress-SHIP2
and GST-ITSN1-SH3A, B, C, D or E, respectively. Cells lysates were
pulled down with glutathione beads and immunoblotted with anti-
SHIP2X5A and anti-GST antibody. Experiments were repeated three
times with similar results.
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the cytoplasm under basal state (Fig. 4c–e). Following stimula-
tion with 50 ng/ml EGF for 5 min, SHIP2 relocalized to plas-
ma membrane (Fig. 4g) as previously described [3], while
ITSN1-S did not (Fig. 4f). This relocalization disappeared at
15 min (Fig. 4l). Interestingly, when SHIP2 and ITSN1-S were
co-expressed, ITSN1-S also relocalized to plasma membrane
upon EGF treatment and accumulated in membrane ruﬄes
(Fig. 4h). Further, we tested the localizations of ITSN1-S
and TSHIP2 which does not interacts with ITSN. Neither
TSHIP2 not ITSN1-S were recruited to plasma membrane in
response to EGF (data not shown).
3.5. EGF stimulation does not modulate the association of
SHIP2 and ITSN1-S
We further addressed whether above recruitment happened
with a change of the interaction between SHIP2 and ITSN1-
S. COS-7 cells transfected with same amount of His-Xpress-
SHIP2 and HA-ITSN1-S were stimulated with EGF for diﬀer-
ent time durations from 0 to 60 min. Anti-Xpress immunopre-
cipitations followed anti-HA immunoblot showed no
signiﬁcant modulation of SHIP2-ITSN1-S binding (Fig. 5A).
This suggests that EGF stimulation does not modify the asso-
ciation of SHIP2 and ITSN1-S, but regulates the localization
of the complex in COS-7 cells.3.6. SHIP2 does not aﬀect the ITSN-mediated ERK1/2 and
JNK phosphorylations in basal state or under EGF
stimulation
Through interaction with sonof-sevenless (Sos), ITSN may
regulate Ras activation, implying that ITSN is involved in
the regulation of the MAP kinase pathway [12]. We thus tested
whether SHIP2 could modulate the eﬀect of ITSN on ERK
and JNK phosphorylations. ITSN1-S was transiently transfec-
ted with or without SHIP2 in COS-7 cells. Cells were treated
with EGF for 0, 5 and 15 min. In basal state as well as under
EGF stimulation, SHIP2 did not show modulation on ITSN-
mediated ERK activation (Fig. 5B). The lower bands showed
in ITSN1-S detection are artiﬁcial bands caused by anti-HA
antibody. Similarly, although ITSN slightly increased JNK
phosphorylation (Fig. 5C, lane 1 and 2), SHIP2 did not show
an evident modulation on ITSN-involved JNK phosphoryla-
tion in basal state. The coupled action of SHIP2 and ITSN
on phospho-JNK was not modiﬁed following EGF stimula-
tion. Taken together, SHIP2 does not aﬀect the ITSN-medi-
Fig. 4. Upon EGF stimulation, ITSN1-S and SHIP2 colocalize to COS-7 cell membrane ruﬄes. COS-7 cells were transfected with HA-ITSN1-S
alone, His-SHIP2 alone or both proteins together and cells were serum starved for 4 h, left untreated or treated with 50 ng/ml EGF for 5 min or
15 min, respectively. SHIP2 and ITSN1-S were localized by immunoﬂuorescence with anti-SHIP2X5A and anti-HA antibodies, respectively,
followed by secondary antibodies coupled to FITC (green) for ITSN and Texas-Red (red) for SHIP2. Arrows indicate membrane ruﬄe localization.
Scale bar = 20 lm. Experiments were repeated three times with similar results.
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ulation, neither JNK phosphorylation in basal state.4. Discussion
ITSN1 (also named as EHSH-1 and Ese-1, or Dap160 in
Drosophila) is a multi-domain protein which exists as two iso-
forms, short and long isoforms. Both isoforms contain two N-
terminal Eps15 homology domains (EH1 and EH2), a coiled-
coil region and ﬁve Src homology domains (SH3A–E). A long-
er isoform, mainly expressed in neurons, has three additional
domains: a Dbl homology domain, a pleckstrin homology do-
main and a C2 domain [17]. Through binding diﬀerent protein
partners, ITSN has been shown to be implicated in MAPK sig-
nalling [12] and endocytosis [13,14]. In the present study, we
identiﬁed ITSN1 as a new protein partner for the phosphati-
dylinositol 5-phosphatase SHIP2 in a two-hybrid screening.
Co-immunoprecipitations of SHIP2 and ITSN in overexpres-
sed system or at the endogenous level mainly in C2C12 myo-
blasts and COS-7 cells conﬁrmed their interaction in vivo
(Fig. 1). Although 3T3 cells and brain exacts which express
both SHIP2 and ITSN, no co-immunoprecipitation was ob-
served. Diﬀerent set of proteins expressed in diﬀerent cells
and tissues may inﬂuence the capacity of SHIP2 and ITSN
to interact by direct binding or through posttranslational mod-
iﬁcations. Also, ITSN-L is expressed in 3T3 cells and brain tis-
sue while not in C2C12 where co-immunoprecipitation took
place. ITSN-L contains additional domains that could play a
role of inhibitor on SHIP2 and ITSN-S binding.
Various proteins were described to interact with ITSN-SH3
domains and their respective binding aﬃnities for the ﬁve SH3
domains of ITSN vary. In pull-down experiments and far Wes-
tern blot analysis, ITSN1-SH3A binds synaptojanin (SYNJ1)
and dynamin strongly, SH3C or SH3E much less and SH3B
and SH3D did not [19]. Sos can bind with SH3A domain[12] as well as SH3C and SH3E domains [20]. In COS-7 cells,
the SH3A, B and D domains bind to a GTPaseactivating pro-
tein (GAP) [21] and neural Wiskott–Aldrich syndrome protein
(N-WASP) bound to the isolated SH3 domains selectively,
with SH3A > E > C > B, D [22]. In the present study,
ITSN1-SH3A, C, D and E domains bind SHIP2 with aﬃnity
SH3D > A > C > E and ITSN-SH3B did not bind (Fig. 3B).
These data imply the potential competitions for ITSN binding
among diﬀerent protein partners.
ITSN is known to stimulate mitogenic signaling pathways
through diﬀerent mechanisms [23,24]. Expression of either
full-length ITSN or the isolated EH region can stimulate acti-
vation of the transcription factor Elk-1 independently of the
classical MEK-ERK pathway [25]. Through binding Sos,
ITSN regulates Ras activation, which is an upstream regulator
of MEK-ERK MAPK pathway [23]. Silencing ITSN attenu-
ated the activation of the ERK[18]. Meanwhile, SHIP2 is able
to negatively regulate the MAPK activation in response to
insulin in CHO-IR cells [26,27] as well as in PDGF and
IGF-I signaling in vascular smooth muscle cells [11]. Neverthe-
less, in our model, SHIP2 did not modulate the ITSN-medi-
ated ERK or JNK activation with or without EGF
stimulation (Fig. 5).
Nevertheless, interestingly, we demonstrated that co-expres-
sion of SHIP2 in COS-7 facilitated the plasma membrane
recruitment of ITSN1-S in response to EGF stimulation
(Fig. 4). In our study, ITSN1-S spreads through cytoplasma
with or without EGF stimulation, which is consistent to previ-
ous study [18]. SHIP2 relocalized to plasma membrane under
EGF stimulation as described previously [3]. When SHIP2
was overexpressed together with ITSN1-S, ITSN1-S could be
relocalized to plasma membrane too. However, TSHIP2 which
does not interact with ITSN was not recruited to plasma mem-
brane under EGF stimulation and ITSN1-S was not recruited
to plasma membrane either. This suggests that SHIP2 recruit-
ment to the plasma membrane was the motor of ITSN recruit-
Fig. 5. EGF eﬀects on the association of SHIP2 and ITSN1-S as well
as ITSN-mediated MAPK activation. (A) EGF stimulation does not
modulate the association of SHIP2 and ITSN1-S. COS-7 cells were
transfected with His-Xpress-SHIP2 and HA-ITSN1-S. Cells were
stimulated with EGF for diﬀerent time durations as indicated. Cell
lysates were immnunoprecipitated with anti-Xpress antibody followed
immunoblot with anti-HA and anti-SHIP2X5A antibody. (B) SHIP2
does not modulate ITSN-mediated ERK phosphorylation. COS-7 cells
were transfected with His-Xpress-SHIP2 alone, HA-ITSN1-S alone or
both proteins together. Cells were untreated or treated with 50 ng/ml
EGF for 5 min or 15 min. Cell lysates were immunoblotted with anti-
phospho-ERK, anti-ERK1/2, anti-HA and anti-SHIP2X5A antibod-
ies. (C) COS-7 cells were transfected with His-Xpress-SHIP2 and HA-
ITSN1-S. Cells were stimulated with EGF for diﬀerent time durations
as indicated. Cell lysates were immunoblotted with anti-phosphor-
JNK, anti-JNK1, anti-HA and anti-SHIP2X5A antibodies. Experi-
ments were repeated three times with similar results.
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endogenous SHIP2 does not. We make the hypothesis that the
endogenous quantity of SHIP2 in the cells is not suﬃcient for
visualizing the recruitment of the overexpressed ITSN. A sim-
ilar study by Zhuang G [10] showed that internalization of
EphA2 receptor was signiﬁcantly inhibited in cells overexpress-ing SHIP2. Conversely, no inhibition was obtained with over-
expressed SHIP2D SAM in COS-7 cells, while endogenous
SHIP2 is also present in this condition.
As an adaptor protein, ITSN1 is involved in clathrin-medi-
ated endocytosis and actin cytoskeleton remodelling through
association with major endocytic complexes [13,14]. Martin
et al. [18] have shown that silencing ITSN attenuated EGFR
internalization. However, previous study [14] showed that
overexpression of Ese1 is suﬃcient to block clathrin-mediated
endocytosis. Through binding epsin and cbl, ITSN may partic-
ipate in the ubiquitination pathway, which provides another
mechanism of ITSN involving in endocytosis [24]. Meanwhile,
SHIP2 siRNAi led to enhanced EGF receptor (EGFR) degra-
dation, increased EGFR ubiquitination and increased associa-
tion of EGFR with c-Cbl ubiquitin ligase, implying the
negative role of SHIP2 in EGFR endocytosis [9]. Our data
(Fig. 4) showed SHIP2 recruited ITSN to cell membrane upon
EGF stimulation without binding alteration (Fig. 5A). EGF
does not enhance their interaction, but relocalizes the
SHIP2-ITSN complex to membrane from cytoplasma. Consid-
ering that ITSN may block endocytic process [14], it is hypoth-
esized that SHIP2 may exert its negative regulation on EGFR
endocytosis through recruiting ITSN to membrane. Cbl is
essential for EGFR endocytosis [18], both SHIP2 and ITSN
are the protein partners of cbl. They may function through
co-operation or competition procedure in EGFR endocytosis.
The role of this recruitment in receptor endocytosis still
needs further investigation. Our data about the association
of SHIP2 and ITSN1 provides a new molecular link between
proteins involved in the receptor endocytosis.
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